IXICO is no ordinary Imaging Contract Research Organisation (iCRO). By unlocking valuable insights into drug safety and efficacy, IXICO has built a highly respected global reputation and a 20-year track record as an end-to-end iCRO. IXICO addresses the complex biomarker challenges associated with neurodegenerative conditions, expertly managing and analysing neuroimaging clinical trials in areas such as Alzheimer’s, Parkinson’s, Huntington's and other rare diseases.
Looking for a particular IXICO employee's phone or email?
The IXICO annual revenue was $8.5 million in 2026.
Bram Goorden is the CEO | Board Director of IXICO.
83 people are employed at IXICO.
The NAICS codes for IXICO are [541, 54, 5413, 54138].
The SIC codes for IXICO are [873, 87].